Dr. Reddys Labs (RDY) Misses Q2 EPS by 1c

Dr. Reddys Labs (NYSE: RDY) reported Q2 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $997 million versus the consensus estimate of $1.02 billion.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

You May Also Be Interested In

• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
• Is the global equity rally broadening? UBS weighs in
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics